Sign in

You're signed outSign in or to get full access.

Enrique Salem

Director at DOCUSIGNDOCUSIGN
Board

About Enrique Salem

Enrique Salem (age 59) is an independent Class III director at Docusign, serving since August 2013, and a partner at Bain Capital Ventures since July 2014; he previously served as President, CEO, and COO of Symantec (now Gen Digital) and holds an A.B. in Computer Science from Dartmouth College . His board-level expertise spans cybersecurity, finance, risk management, and governance; the Board has determined he is independent under Nasdaq standards .

Past Roles

OrganizationRoleTenureCommittees/Impact
Symantec (Gen Digital)President, CEO, COOPrior to 2014 (not specified)Senior leadership in cybersecurity operations
Bain Capital VenturesPartnerSince July 2014Early-stage infra software/cyber specialist; broad investor network

External Roles

OrganizationRoleTenureCommittees/Impact
Rubrik, Inc.DirectorCurrent (as of 2025)Member, Nominating & Corporate Governance Committee
Atlassian CorporationDirector (retired)2013–Apr 2025Audit and Nominating Committee member; retired April 14, 2025
FireEye, Inc. (prior)DirectorPrior service (not current)Cybersecurity oversight
ForeScout Technologies, Inc. (prior)DirectorPrior service (not current)Network security oversight

Board Governance

  • Committee assignments: Audit Committee member; Audit Committee composition includes Chair Teresa Briggs, and members James Beer, Enrique Salem, and Anna Marrs; each member deemed independent, “financially sophisticated,” and an “audit committee financial expert” .
  • Independence: The Board determined Salem is independent under SEC/Nasdaq rules; 8 of 9 continuing directors are independent .
  • Attendance: The Board met 24 times in FY25; each director attended at least 75% of aggregate Board and committee meetings; all continuing directors attended the 2024 Annual Meeting .
  • Risk oversight: The Audit Committee oversees financial reporting, internal controls, compliance, and cybersecurity risk; management provides regular cyber updates to the Board/Audit Committee .

Fixed Compensation

ComponentAmount/TermsFY25 Salem
Cash Retainer$46,500 annual$46,500
Committee FeesAudit Committee non-chair: $15,000 annual$15,000
Chair/Lead FeesNot applicable (not Chair/Lead)$0
Meeting FeesNot listed in policy$0 (not disclosed)
Equity – Annual RSUTarget $250,000 grant-date fair value, vests quarterly; accelerates on change-in-controlStock awards recognized: $249,971
Total FY25 Director CompCash + Equity$311,471 total; $61,500 cash; $249,971 equity

Notes: Non-employee director RSUs are granted on the Annual Meeting date and generally vest in four equal quarterly installments; all annual grants vest in full upon change-of-control .

Performance Compensation

Performance-Based ComponentTermsFY25 Salem
PSUs/Performance Metrics for DirectorsNone; non-employee director compensation comprises cash fees and time-based RSUs (no performance conditions)Not applicable

Other Directorships & Interlocks

  • Bain Capital Ventures role: Salem is a BCV partner; BCV entities hold significant positions in various technology companies (e.g., Rubrik); BCV governance is directed by BCVI’s Executive Committee (Salem is a member), indicating broad network interlocks but none disclosed as related-party at Docusign .
  • No Docusign related-party transactions involving Salem disclosed since Feb 1, 2024; a disclosed transaction involved Jackson Square Ventures/Director Peter Solvik (OneNotary financing), not Salem .

Expertise & Qualifications

  • Cybersecurity/information security expertise; identified in Board skills matrix; prior Symantec CEO/COO enhances oversight of cyber risk and enterprise-scale operations .
  • Finance and risk management experience; Audit Committee financial expert designation supports effectiveness in financial oversight .
  • Governance: prior public company board experience and committee service (Audit, Nominating) across multiple companies .
  • Education: A.B. in Computer Science (Dartmouth) .

Equity Ownership

MetricValueNotes
Total Beneficial Ownership (DOCU common)163,333 shares<1% of shares outstanding
Shares Subject to Outstanding RSUs2,137 sharesAs of Jan 31, 2025
Options Outstanding0None disclosed
Ownership Guidelines (Directors)3.0x annual Board retainerApplies to all non-employee directors
Compliance StatusMet or within allowed timeAs of Jan 31, 2025, all non-employee directors met or had time to meet guidelines
Hedging/Pledging PolicyProhibitedShort sales, hedging, pledging, margin accounts prohibited

Governance Assessment

  • Strengths:

    • Independence and financial expertise on Audit Committee (Salem designated audit committee financial expert), strengthening oversight of reporting, controls, and cybersecurity .
    • Attendance and engagement: Board met 24 times in FY25; directors attended ≥75%, indicating active oversight; Salem participated in committee reports included in the proxy .
    • Alignment policies: Mandatory stock ownership guidelines (3x retainer) with compliance or timeline adherence as of Jan 31, 2025; prohibition on hedging/pledging enhances alignment with shareholders .
    • No related-party transactions involving Salem disclosed; Docusign maintains formal related person transaction policy administered by the Audit Committee .
  • Potential considerations/monitoring:

    • Venture interlocks: As a BCV partner and director at Rubrik (and prior at Atlassian), monitor any prospective transactions between Docusign and BCV portfolio companies for independence and related-party review; Docusign policy clarifies when director-affiliated entities are considered related persons and requires Audit Committee review where applicable .
    • Classified board structure persists (Board concluded appropriate for size/tenure/industry), but investors may prefer declassification; continued engagement and rationale disclosure are ongoing .
  • Red flags:

    • None disclosed for Salem regarding conflicts, related-party transactions, hedging/pledging, or attendance; director compensation is standard (cash retainer + committee fee + annual RSUs) with no unusual guarantees or option repricings .